Are We Right to Consider Mesenchymal Stem Cells to Be a New Perspective for Patients with Juvenile Idiopathic Arthritis?
Juvenile idiopathic arthritis (JIA) is the most common cause of chronic arthritis in childhood. Up to 50% of patients are resistant to standard therapy, which includes non-steroid anti-inflammatory drugs, corticosteroids, disease-modifying anti-rheumatic drugs and biologic therapies. Intra-articular injection of mesenchymal stem cells (MSCs) is proposed as a new approach to JIA treatment. MSCs can modulate inflammation via mechanisms of both adaptive and innate immune response. They are able to inhibit T and B cell proliferation, promote regulatory T cells, suppress the maturation of dendritic cells, stimulate macrophage differentiation into M2 phenotype and reduce effectiveness of natural killer cells. They also secrete plethora of soluble factors which influence joint inflammation. Recent clinical studies reviewed in the article provide promising results which may suggest including intra-articular injection of MSCs in therapy of patients with oligoarticular JIA.
KeywordsMesenchymal stem cells Juvenile idiopathic arthritis Pathogenesis
This work was partially supported by the grant No. 503/8-000-04/503-81-002 from Medical University of Lodz, Poland.
Compliance with Ethical Standards
Conflict of interest
Authors declare no conflict of interests.
- Contreras RA, Figueroa FE, Djouad F et al (2016) Mesenchymal stem cells regulate the innate and adaptive immune responses dampening arthritis progression. Stem Cells Int 2016:3162743Google Scholar
- Hou J, Ouyang Y, Deng H et al (2016) Whole-genome expression analysis and signal pathway screening of synovium-derived mesenchymal stromal cells in rheumatoid arthritis. Stem Cells Int 2016:1375031Google Scholar
- Swart J, Wulffraat N, Prakken BJ et al (2015) Mesenchymal stromal cell treatment in juvenile idiopathic arthritis: a pilot study [abstract]. Arthritis Rheumatol 67:3813–3814Google Scholar
- Wang L, Zhang Y, Li H et al (2016) Clinical observation of employment of umbilical cord derived mesenchymal stem cell for juvenile idiopathic arthritis therapy. Stem Cells Int 2016:9165267Google Scholar
- Zhang Y, Khan D, Delling J et al (2012) Mechanisms underlying the osteo- and adipo-differentiation of human mesenchymal stem cells. Sci World J 2012:793823Google Scholar